NICE recommends Xarelto for DVT and PE - 07-Jun-2012

In final draft guidance, the National Institute for Health and Clinical Excellence (NICE) recommends the use of Xarelto (rivaroxaban) from Bayer HealthCare as an option for treating deep vein thrombosis (DVT) and preventing recurrent DVT and pulmonary embolism in adults diagnosed with acute DVT.

Related News

Related Thrombosis Information

Thrombosis Medical Journal Abstracts

25-hydroxyvitamin D concentrations and risk of venous thromboembolism in the general population with 18,791 participants

Journal of Thrombosis and Haemostasis 29 December 2012

Platelet dysfunction associated with the novel Trp29Cys thromboxane A2 receptor variant

Journal of Thrombosis and Haemostasis 29 December 2012

Thrombosis Medical Apps

Thrombosis Guidelines

Free

Antithrombotic Therapy apc

£3.17
Back to top

Latest News

10 May 2015
18 May 2013
18 May 2013